There are reports that a blood-coagulating drug used primarily to treat rare forms of hemophilia has been used on wounded American troops in Iraq, even though it can cause clots that lead to heart attacks and strokes.
The drug is known as Recombinant Activated Factor VII. The FDA has approved in the United States for treating forms of hemophilia that affect fewer than 3,000 Americans.
te Army medical command considers it a medical breakthrough that gives front-line physicians a way to control deadly bleeding. Physicians in Iraq have injected it into more than 1,000 patients, according to the Baltimore Sun.
For more go here.
